NAD⁺
For in-vitro laboratory research use only. Not intended for human consumption, veterinary, diagnostic, or clinical use.
Description
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential intracellular coenzyme present in every living cell and a central node in cellular bioenergetics. It is supplied as an investigational laboratory compound for use in longevity research, mitochondrial-pathway research, and redox-metabolism research.
Laboratory research studies have positioned NAD⁺ as a foundational metabolic cofactor that cycles between its oxidized (NAD⁺) and reduced (NADH) states, enabling efficient ATP production through glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation. Beyond its electron-carrier role, NAD⁺ serves as the obligate substrate for sirtuin deacylases (SIRT1·SIRT7), poly(ADP-ribose) polymerases (PARPs), and CD38, linking cellular energy state to gene-expression programs, DNA-maintenance signaling, and stress-adaptation responses (Chini et al., 2021, Cell Metabolism).
NAD⁺ is investigated across longevity research, neurobiology research, cardiovascular-pathway research, and metabolic-pathway research. Reported research observations include progressive age-associated decline in tissue NAD⁺ pools, modulation of mitochondrial efficiency under stress, and links between NAD⁺ bioavailability and axonal-integrity signaling via the NMNAT and SARM1 axis. The coenzyme is frequently studied alongside the NNMT inhibitor approach for probing nicotinamide salvage, and in parallel with mitochondrial-derived peptide signaling in energy-metabolism research models. NAD⁺ remains one of the most extensively studied coenzymes in modern biomedical research.
The compound is supplied as a lyophilized powder to ensure optimal stability during storage and handling.







